Q2 2026 Anika Therapeutics Inc Earnings Call Transcript

Jul 29, 2026 / 12:30 PM GMT

Release Date Price: €13.9 (+5.30%)

Transcript 10-Q8-K

Key Points

Positve

Anika Therapeutics Inc (ANIK) reported a 17% increase in commercial channel revenue, marking a record level for the company.
The company achieved significant gross margin expansion to 65%, one of the highest levels in recent years.
International revenue reached a record $12.6 million, increasing 22% year-over-year, driven by broad-based growth across markets and product categories.
Adjusted EBITDA for the quarter was $7.1 million, representing an adjusted EBITDA margin of 22%, the strongest quarterly profitability performance since 2020.
Anika Therapeutics Inc (ANIK) raised its full-year 2026 guidance, expecting total company revenue growth of 5% to 10% and adjusted EBITDA margin guidance to 13% to 17%.

Negative

The company noted potential revenue variability due to customer ordering patterns, which could impact future quarters.
There is ongoing pricing pressure in the OEM channel, which could affect future profitability despite volume growth.
The timing of regulatory approval for Hyalafast in the U.S. remains uncertain, potentially impacting future revenue projections.
Cash generation has lagged behind other metrics, with expectations for stronger free cash flow pushed to the second half of the year.
The company faces challenges in maintaining the favorable product mix that contributed to the current gross margin levels.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ANIK.OQ - Anika Therapeutics Inc
Q2 2026 Anika Therapeutics Inc Earnings Call
Jul 29, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, ladies and gentlemen, and welcome to the Anica's second quarter earnings conference call. I would now like to turn the call over to Mr. Matt Hall, Executive Director, Corporate Development and Investor Relations. Please proceed.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, and thank you for joining us for Anica's second quarter 2026 conference call and webcast. I'm Matt Hall, Annica's Executive Director of Corporate Development and Investor Relations. Our earnings press release was issued earlier this morning and is available on our Investor

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.